Cannabinoid receptor 1 promotes hepatic lipid accumulation and lipotoxicity through the induction of SREBP-1c expression in zebrafish (Q47074172)

5 January 2018

title

Cannabinoid receptor 1 promotes hepatic lipid accumulation and lipotoxicity through the induction of SREBP-1c expression in zebrafish (English)

1 reference

5 January 2018

0 references

0 references

0 references

Cannabinoid receptor 1

1 reference

GOA release 2020-03-11

author name string

Wan-Yu Pai

1

1 reference

5 January 2018

Chia-Chun Hsu

2

1 reference

5 January 2018

Chi-Yu Lai

3

1 reference

5 January 2018

Trent-Zarng Chang

4

1 reference

5 January 2018

Yu-Lun Tsai

5

1 reference

5 January 2018

Guor Mour Her

6

1 reference

5 January 2018

publication date

12 January 2013

1 reference

5 January 2018

published in

Transgenic Research

1 reference

5 January 2018

volume

22

1 reference

5 January 2018

issue

4

1 reference

5 January 2018

page(s)

823-838

1 reference

5 January 2018

Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age.

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11248-012-9685-0

Sex difference in the liver of hepatocyte-specific Pten-deficient mice: A model of nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-012-9685-0

Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-012-9685-0

Bimodal control of stimulated food intake by the endocannabinoid system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-012-9685-0

The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-012-9685-0

Hallucinatory and rewarding effect of salvinorin A in zebrafish: kappa-opioid and CB1-cannabinoid receptor involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-012-9685-0

Liver-specific expression of p53-negative regulator mdm2 leads to growth retardation and fragile liver in zebrafish.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-012-9685-0

Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-012-9685-0

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-012-9685-0

Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-012-9685-0

Endocannabinoid control of food intake and energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-012-9685-0

Leptin-regulated endocannabinoids are involved in maintaining food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-012-9685-0

Expression of the cannabinoid CB1 receptor in the gymnotiform fish brain and its implications for the organization of the teleost pallium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-012-9685-0

In vivo studies of liver-type fatty acid binding protein (L-FABP) gene expression in liver of transgenic zebrafish (Danio rerio).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-012-9685-0

Imbalance in liver homeostasis leading to hyperplasia by overexpressing either one of the Bcl-2-related genes, zfBLP1 and zfMcl-1a

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-012-9685-0

Overexpression of gankyrin induces liver steatosis in zebrafish (Danio rerio).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-012-9685-0

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-012-9685-0

Antifibrogenic role of the cannabinoid receptor CB2 in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-012-9685-0

Distribution of cannabinoid receptor 1 in the CNS of zebrafish.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-012-9685-0

Molecular mechanisms involved in NAFLD progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-012-9685-0

Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-012-9685-0

A shifted repertoire of endocannabinoid genes in the zebrafish (Danio rerio).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-012-9685-0

A novel role for the endocannabinoid system during zebrafish development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-012-9685-0

Endocannabinoid system in Xenopus laevis development: CB1 receptor dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-012-9685-0

Fasting induces CART down-regulation in the zebrafish nervous system in a cannabinoid receptor 1-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-012-9685-0

Peripheral, but not central, CB1 antagonism provides food intake-independent metabolic benefits in diet-induced obese rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-012-9685-0

Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-012-9685-0

The endocannabinoid system as an emerging target of pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-012-9685-0

The endocannabinoid nervous system: unique opportunities for therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-012-9685-0

Viral 2A peptides allow expression of multiple proteins from a single ORF in transgenic zebrafish embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-012-9685-0

Increase of hepatic fat accumulation by liver specific expression of Hepatitis B virus X protein in zebrafish

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-012-9685-0

The localization and physiological effects of cannabinoid receptor 1 in the brain stem auditory system of the chick

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-012-9685-0

Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-012-9685-0

Cannabinoid type 1 receptor blockade promotes mitochondrial biogenesis through endothelial nitric oxide synthase expression in white adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-012-9685-0

Beneficial paracrine effects of cannabinoid receptor 2 on liver injury and regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-012-9685-0

Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-012-9685-0

The endocannabinoid system in the brain of Carassius auratus and its possible role in the control of food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-012-9685-0

The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11248-012-9685-0

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

21 January 2018

1 reference

12 December 2020

Endocannabinoid receptor CB2 in nonalcoholic fatty liver disease

1 reference

12 December 2020

Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications

1 reference

12 December 2020

Splanchnic balance of free fatty acids, endocannabinoids, and lipids in subjects with nonalcoholic fatty liver disease

1 reference

12 December 2020

Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study

1 reference

12 December 2020

Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis

1 reference

12 December 2020

Anandamide modulates growth and lipid metabolism in the zebrafish Danio rerio

1 reference

12 December 2020

Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma

1 reference

12 December 2020

Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats

1 reference

12 December 2020

Sterol regulatory element binding proteins (SREBPs): controllers of lipid synthesis and cellular uptake

1 reference

12 December 2020

10.1007/S11248-012-9685-0

Identifiers

DOI

1 reference

5 January 2018

1 reference

5 January 2018